Skip to search formSkip to main contentSkip to account menu

cyclophosphamide/prednisone/procarbazine/vincristine protocol

Known as: Cyclophosphamide/Prednisone/Procarbazine/Vincristine, COPP, Cytoxan-Oncovin-Procarbazine-Prednisone Regimen 
A derivative of the original MOPP regimen consisting of cyclophosphamide, vincristine, procarbazine and prednisone used as an initial treatment for… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Background: The BEACOPP regimen has proved to be superior to the conventional drug combination COPP/ABVD in the HD9 trial. In the… 
2004
2004
N-Myristoyltransferase (NMT) is an emerging therapeutic target that catalyzes the attachment of myristate to the N terminus of an… 
Highly Cited
2002
Highly Cited
2002
PURPOSE To investigate whether treatment results in intermediate-stage Hodgkin's lymphoma can be improved by rapid application of… 
2000
2000
Abstract Thyroid disease, especially hypothyroidism, is one of the more frequently encountered late endocrine sequelae of… 
1999
1999
Although Hodgkin's disease (HD) is one of the common malignancies in childhood, there is limited information from developing… 
Highly Cited
1998
Highly Cited
1998
The BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) regimen, a rearranged… 
1997
1997
Heme-hemopexin supports and stimulates proliferation of human acute T-lymphoblastic (MOLT-3) cells, suggesting the participation… 
1988
1988
Twenty-one patients with tumor stage mycosis fungoides (MF) with or without lymph node (LN) involvement, were treated with total…